Annual report pursuant to Section 13 and 15(d)

Accrued Expenses

v3.7.0.1
Accrued Expenses
 12 Months Ended
Dec. 31, 2016
Payables and Accruals [Abstract]  
Accrued Expenses

7. ACCRUED EXPENSES

 

Accrued expenses consisted of the following:

 

    December 31,  
    2016     2015  
Accrued clinical operations and trials costs   $ 1,647,490     $ 365,188  
Accrued product development costs     713,426       152,018  
Accrued compensation     778,250       —  
Accrued other     117,289       45,073  
Total   $ 3,256,455     $ 562,279